Danel (Adir Yeoshua) Ltd (TLV:DANE)
46,950
-90 (-0.19%)
Jun 8, 2026, 4:09 PM IDT
Danel (Adir Yeoshua) Revenue
Danel (Adir Yeoshua) had revenue of 729.58M ILS in the quarter ending March 31, 2026, with 3.58% growth. This brings the company's revenue in the last twelve months to 2.93B, up 4.76% year-over-year. In the year 2025, Danel (Adir Yeoshua) had annual revenue of 2.90B with 5.26% growth.
Revenue (ttm)
2.93B
Revenue Growth
+4.76%
P/S Ratio
0.96
Revenue / Employee
683.44K
Employees
4,288
Market Cap
2.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.90B | 145.18M | 5.26% |
| Dec 31, 2024 | 2.76B | 259.93M | 10.40% |
| Dec 31, 2023 | 2.50B | 135.37M | 5.73% |
| Dec 31, 2022 | 2.36B | 75.20M | 3.29% |
| Dec 31, 2021 | 2.29B | 303.89M | 15.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 54.78B |
| Amal Holdings A.D. | 2.18B |
| Novolog (Pharm-Up 1966) | 1.80B |
| Ilex Medical | 906.15M |
| Kamada | 573.62M |
| SofWave Medical | 301.12M |
| BrainsWay | 177.50M |
| Bait Bakfar | 111.90M |